Sec. 38a-504b. Cancer clinical trials that are eligible for coverage. - Connecticut Statutes

      Sec. 38a-504b. Cancer clinical trials that are eligible for coverage. In order to be eligible for coverage of routine patient care costs, as defined in section 38a-504d, a cancer clinical trial shall be conducted under the auspices of an independent peer-reviewed protocol that has been reviewed and approved by: (1) One of the National Institutes of Health; or (2) a National Cancer Institute affiliated cooperative group; or (3) the federal Food and Drug Administration as part of an investigational new drug or device exemption; or (4) the federal Department of Defense or Veterans Affairs. Nothing in sections 38a-504a to 38a-504g, inclusive, shall be construed to require coverage for any single institution cancer clinical trial conducted solely under the approval of the institutional review board of an institution, or any trial that is no longer approved by an entity identified in subdivision (1), (2), (3) or (4) of this section.

      (P.A. 01-171, S. 9, 25.)

      History: P.A. 01-171 effective January 1, 2002.

      See Sec. 38a-542b for similar provisions re group policies.